Unifeed
UN / EBOLA WRAP
STORY: UN / EBOLA WRAP
TRT: 3:50
SOURCE: WHO/ UNTV/ CDC
LANGUAGE: ENGLISH / NATS
DATELINE: 5 AUGUST 2014, GENEVA, NEW YORK CITY / 4 AUGUST 2014, GENEVA / CDC HANDOUIT
WHO - 5 AUGUST 2014, GENEVA
1. Pan right, WHO presser
2. SOUNDBITE (English) Dr Marie-Paule Kieny, WHO Assistant Director-General - Health Systems and Innovation:
“One of the things driving fear and panic in communities-and the world- is the belief that there is no treatment for Ebola Virus disease. However, tremendous work has been done to accelerate our knowledge of potential Ebola interventions and furnish us with some promising tools.”
3. Cutaway, press
4. SOUNDBITE (English) Dr Marie-Paule Kieny, WHO Assistant Director-General - Health Systems and Innovation:
“We have agreed that whole blood therapies and convalescent serums may be used to treat Ebola virus disease, and that all efforts must be invested into helping affected countries use them safely. Two promising vaccine candidates were identified. One is called Chimpanzee Adenovirus -Ebola and the other one, VSV-EBOLA. Safety studies are currently underway in the United States of America and soon to start in Europe and Africa.”
5. Cutaway, press
6. SOUNDBITE (English) Dr Marie-Paule Kieny, WHO Assistant Director-General - Health Systems and Innovation:
“It is absolutely unprecedented, there is no doubt…it is unprecedented in the willingness that everybody has to move as quickly as possible and this includes the regulators, as we know, the regulators have a very important role in ensuring that what is used in the human population is effective, so they are really helping us in order to facilitate processes that while trying to preserve as much as possible, safety, this is very important, safety should be preserved, that at the same time the development goes very quickly.”
UNTV- STILL 5 AUGUST 2014, NEW YORK CITY
7. Ban Ki-moon, Margaret Chan, David Nabarro and other officials in seated at table
UNTV- 5 AUGUST 2014, NEW YORK CITY
8. Zoom in, Ban, Chan, Nabarro
9. SOUNDBITE (English) Ban Ki-moon, Secretary-General, United Nations:
“Banning flights and shipping services will not keep Ebola from spreading, but it will keep medical teams from reaching people most in need. Stigma and rumour can do just as much damage as the virus itself. It is crucial to remember that Ebola can be avoided and controlled. The virus has been contained elsewhere in the past, and we can do it today as well. We know what to do and what needs to be done.
I call on the international community to contribute to the WHO Roadmap and to provide the $600 million needed for supplies in West Africa. The world can no longer afford to short-change global public health.”
WHO - 4 AUGUST 2014, GENEVA
10. Various shots, experts meeting
FILE – CDC HANDOUT
11. Various shots, technicians working in lab
After two days of discussion on potential Ebola therapies and vaccines, more than 150 participants, representing the fields of research and clinical investigation, ethics, legal, regulatory, financing, and data collection, identified several therapeutic and vaccine interventions that should be the focus of priority clinical evaluation.
Addressing the press following the meeting of experts, the World Health Organization’s (WHO) Assistant Director-General Marie-Paule Kieny
said that part of what was driving panic around the world was the belief that there is no treatment for Ebola Virus disease but that “tremendous work has been done to accelerate our knowledge of potential Ebola interventions and furnish us with some promising tools.”
Kieny said that two “promising” vaccines were identified and that experts had agreed to “whole blood therapies and convalescent serums” to treat Ebola and that all efforts must be invested into helping affected countries use them safely.
WHO said that existing supplies of all experimental medicines are limited. While many efforts are underway to accelerate production, supplies will not be sufficient for several months to come. Kieny called the response to this outbreak unprecedented, in that all parties involved, from the scientists to the regulators - have to move as quickly as possible.
Earlier, Secretary-General Ban Ki-moon convened a meeting with senior UN leaders and experts to discuss next steps in managing the epidemic, warned that the world can no longer afford to short-change global public health.
Later, he read a statement urging airlines and shipping companies not to cancel flights and docking to the affected countries, adding that such restrictions will only keep medical teams from reaching people most in need.
And called on the international community to the support the World Health Organization’s Roadmap and to provide $600 million for supplies in West Africa.
WHO said that right now none of these vaccines or therapies have been approved for human use to prevent or treat EVD. They said a number of candidate vaccines and therapies have been developed and tested in animal models and some have demonstrated promising results.
Safety in humans is also unknown, raising the possibility of adverse side effects when administered. Use of some of these products is demanding and requires intravenous administration and infrastructure, such as cold chain, and facilities able to offer a good and safe standard of care.
The experts noted that the recipients of experimental interventions, location of studies, and study design, should be based on the aim to learn “as much as we can as fast as we can without compromising patient care or health worker safety.”
Download
There is no media available to download.









